Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2008
06/17/2008US7387798 Method and composition for resuscitation
06/17/2008US7387791 Oral administering; tablet with enteric coating; supplying drug to gastrointestinal systems
06/17/2008US7387780 Soluble interleukin-20 receptor
06/17/2008US7387779 Anti-angiogenic proteins and fragments and methods of use thereof
06/17/2008US7387778 Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders
06/17/2008US7387777 Methods of treating hemophilia or von willebrand disease with p-selectin
06/17/2008US7387614 Drug delivery to the inner ear and methods of using same
06/17/2008US7387271 Immunostimulatory combinations
06/17/2008CA2356380C Immunosuppressive effects of pteridine derivatives
06/17/2008CA2303884C Inorganic-polymer complexes for the controlled release of compounds including medicinals
06/17/2008CA2294457C Pharmaceutical composition for application to mucosa
06/17/2008CA2255062C Process of purification of cyclosporin
06/17/2008CA2247336C Parapoxviruses containing foreign dna, their production and their use in vaccines
06/17/2008CA2240394C Ob protein receptor and related compositions and methods
06/17/2008CA2189051C Composition for delivery of toxic radioisotopes to the cell nucleus and use
06/17/2008CA2187162C Dna encoding precursor of interleukin-1.beta. converting enzyme-related cysteine proteinase iii (icerel iii)
06/17/2008CA2186497C Factor xa inhibitors
06/17/2008CA2182199C Formulations for il-11
06/17/2008CA2102693C Protein formulation comprising growth hormone
06/17/2008CA2067250C Inhibition of padgem-mediated cell binding
06/17/2008CA1341575C Tumor necrosis factor (tnf) inhibitory protein and its purification
06/14/2008CA2613409A1 Protein stabilization formulations
06/13/2008CA2614162A1 Tissue fusion method using collagenase for repair of soft tissue
06/12/2008WO2008070859A2 Treatment of skin conditions by dickkopf1 (dkk1)
06/12/2008WO2008070858A1 Inhibiting translation of abrerrant dnmt3b transcripts in cancer cells using inhibitory nucleic acids
06/12/2008WO2008070833A2 Use of sh2 stat3/stat1 peptidomimetices as anticancer drugs
06/12/2008WO2008070823A2 Substrate-mimetic akt inhibitor
06/12/2008WO2008070743A2 Methods of increasing cancer sensitivity to chemotherapeutic agents using chimeric isf35
06/12/2008WO2008070698A1 A controlled release enzymatic composition and methods of use
06/12/2008WO2008070672A2 Compositions and methods to treat cancer with cupredoxins and cpg rich dna
06/12/2008WO2008070666A2 Compositions and methods to treat cancer with cpg rich dna and cupredoxins
06/12/2008WO2008070564A1 Uses of muramyl dipeptide (mdp) for treating inflammation
06/12/2008WO2008070552A2 Inhibitors of protein tyrosine phosphatase for the promotion of physiological cardiac hypertrophy
06/12/2008WO2008070513A1 Modulation of polysialylated neural adhesion molecules (psa-ncam) as a regulator of ocular disease
06/12/2008WO2008070387A1 Use of hydrolytic and oxidative enzymes to dissolve biofilm in ears
06/12/2008WO2008070368A2 Methods and compositions for skin care
06/12/2008WO2008070355A2 Designed degradable cage coated with mineral layers for spinal interbody fusion
06/12/2008WO2008070353A2 Tissue plasminogen activator variant uses
06/12/2008WO2008070303A2 Therapeutics to inhibit mll-menin interaction for treating leukemia
06/12/2008WO2008070141A2 Compositions for delivery of therapeutic agents
06/12/2008WO2008070132A2 Methods of use of trk receptor modulators
06/12/2008WO2008070117A1 Conjoint therapy for treating fibrotic diseases
06/12/2008WO2008070112A1 Overexpression of wnt ligands and treatment of lytic bone diseases
06/12/2008WO2008070097A1 Use of il-27 agonists to reduce immune mediated abortion
06/12/2008WO2008070083A2 Filter media using peptide-based antimicrobials
06/12/2008WO2008070049A2 Peptide and treatment for hiv-1 infection
06/12/2008WO2008069917A2 Novel cyclic peptides
06/12/2008WO2008069876A2 Amidated dopamine neuron stimulating peptides for cns dopaminergic upregulation
06/12/2008WO2008069824A2 Compositions and methods for transport of molecules with enhanced release properties across biological barriers
06/12/2008WO2008069652A1 Combinations of a sphingolipid and an hmg-coa reductase inhibitor for treating hypercholesterolemia
06/12/2008WO2008069290A1 Anti-hiv drug comprising fusion protein containing multimeric actinohivin, polypeptide constituting the same, gene encoding the polypeptide and method for producing the anti-hiv drug
06/12/2008WO2008069020A1 Method for improving solubility of protein, method for stabilizing dissolved state of protein-containing aqueous solution, and composition
06/12/2008WO2008068885A1 Protecting agent for use in lyophilization and method for production of physiologically active substance
06/12/2008WO2008068866A1 Ophthalmic composition
06/12/2008WO2008068765A2 Compositions and methods for inhibiting hiv-1 replication and integrase activity
06/12/2008WO2008068621A2 Combination product with ido inhibitor and tumor targeted ifn-gamma
06/12/2008WO2008068487A1 Truncated pth peptides with a cyclic conformation
06/12/2008WO2008068393A1 Novel use of a homeopathic strain of insulinum for preparing homeopathic medicaments, active on herpes, herpes zoster and warts and on rna viruses
06/12/2008WO2008067833A1 Use of ghrelin to reverse hair loss
06/12/2008WO2008067831A2 Use of ghrelin, an analogue thereof or a pharmaceutically acceptable salt thereof
06/12/2008WO2008067609A1 Method and composition for reducing reperfusion injury
06/12/2008WO2008041106A3 Use of growth hormone secretagogues to block or inhibit the renin-angiotensin system
06/12/2008WO2008037449A3 Use of at least one isoform of progesterone receptor membrane component 1 (pgrmc1)
06/12/2008WO2008033473A3 Assay for the detection of phosphorylated pth
06/12/2008WO2008028684A3 Peptides with high affinity for the prolactin receptor
06/12/2008WO2008025425A9 Microparticles based on an amphiphilic copolymer and on active ingredient(s) with modified release and pharmaceutical formulations containing same
06/12/2008WO2008020596A3 Treating or preventing cancers over-expressing reg4 or kiaa0101
06/12/2008WO2008008348A3 Method and compositions for treating stroke with fever
06/12/2008WO2008005487A3 Peptide sequences for modulation of protein kinase c
06/12/2008WO2008003514A3 Human il-4 muteins in combination with chemotherapeutics or pro-apoptotic agents in cancer therapy
06/12/2008WO2007132338A3 IL-1α IMMUNIZATION INDUCES AUTOANTIBODIES PROTECTIVE AGAINST ATHEROSCLEROSIS
06/12/2008WO2007087370A3 Tat-038 and methods of assessing and treating cancer
06/12/2008WO2007068895A9 Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or flt1 antagonist for treating cancer
06/12/2008WO2007048857A8 Use of tgf-$g(b)1 inhibitor peptides in the preparation of an immune response modulating agent
06/12/2008WO2007047754A9 Mtor pathway theranostic
06/12/2008WO2007028968A9 Method of treating myasthenia gravis
06/12/2008WO2005046434A8 Compositions and methods for diagnosing and treating mental disorders
06/12/2008WO2003095622A8 Proteins associated with cell growth, differentiation, and death
06/12/2008US20080140184 Scaffold device
06/12/2008US20080139811 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection
06/12/2008US20080139785 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
06/12/2008US20080139576 5-Substituted 1,1-Dioxo- 1,2,5- Thiadiazolidin-3-One Derivatives
06/12/2008US20080139483 Drug combination for hypertensive disorders
06/12/2008US20080139482 Intermediate duration neuromuscular blocking agents and antagonists thereof
06/12/2008US20080139481 High binding activity modified peptides; blood stability, receptor selectivity, barrier crossing; N-terminus moieties
06/12/2008US20080139480 Imatinib resistant leukemia; synergistic treatment with such as ciclopirox
06/12/2008US20080139479 Intelligent drug carrier capable of selective delivery; reduced side effects; isolated, labeled peptide of amino acid sequence 7; antibodies; kits
06/12/2008US20080139478 IL-10 Related Peptides For Wound Healing
06/12/2008US20080139477 Introduced DNA sequences are replicated, stably retained and segregated independent of continuous selection pressure
06/12/2008US20080139476 Caspase-8 interacting proteins
06/12/2008US20080139475 Inhibition of atf2 activity to treat cancer
06/12/2008US20080139474 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
06/12/2008US20080139473 Preventing or reducing cerebral ischemia and/or reperfusion injury from surgical operations; utilizing kunitz domain polypeptides
06/12/2008US20080139472 Preventing and/or restoring cognitive dysfunction in fragile X syndrome; AMPA potentiation
06/12/2008US20080139471 Compositions and methods to prevent cancer with cupredoxins
06/12/2008US20080139470 Erythropoietin compositions
06/12/2008US20080139469 Containing fibroblast growth factor or partial peptide active ingredient; promoting follicle growth
06/12/2008US20080139468 Method For Control of Invasion and Use of Adiponectin
06/12/2008US20080139467 Method and Products For the Selective Degradation of Proteins
06/12/2008US20080139466 Dna Sequence and Expressed Recombinant Glycoproteins Related to Feline Thyrotropin
1 ... 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 ... 3163